Spanish version of the screening Örebro Musculoskeletal Pain Questionnaire: a cross-cultural adaptation and validation

Health and Quality of Life Outcomes

Manuel González-Sánchez¹  Antonio Ignacio Cuesta-Vargas² 

[1] Departamento de psiquiatría y fisioterapia, Instituto de Investigación Biomédico de Málaga (IBIMA), Universidad de Málaga, C/ Arquitecto Francisco Peñalosa, Ampliación Campus Teatinos, Malaga, 29071, Spain;School of Clinical Sciences, Faculty of Health at the Queensland University of Technology, Queensland, Australia

关键词: Measurement;    Clinimetric;    Factor analysis;    Outcome;    Validity;    Reliability;    Musculoskeletal pain;   

Others  :  1164501
DOI  :  10.1186/s12955-014-0157-5

 received in 2014-06-05, accepted in 2014-10-09,  发布年份 2014

【 摘 要 】

Background

Spanish is one of the five most spoken languages in the world. There is currently no published Spanish version of the Örebro Musculoskeletal Pain Questionnaire (OMPQ). The aim of the present study is to describe the process of translating the OMPQ into Spanish and to perform an analysis of reliability, internal structure, internal consistency and concurrent criterion-related validity.

Methods

Design: Translation and psychometric testing. Procedure: Two independent translators translated the OMPQ into Spanish. From both translations a consensus version was achieved. A backward translation was made to verify and resolve any semantic or conceptual problems. A total of 104 patients (67 men/37 women) with a mean age of 53.48 (±11.63), suffering from chronic musculoskeletal disorders, twice completed a Spanish version of the OMPQ. Statistical analysis was performed to evaluate the reliability, the internal structure, internal consistency and concurrent criterion-related validity with reference to the gold standard questionnaire SF-12v2.

Results

All variables except ¿Coping¿ showed a rate above 0.85 on reliability. The internal structure calculation through exploratory factor analysis indicated that 75.2% of the variance can be explained with six components with an eigenvalue higher than 1 and 52.1% with only three components higher than 10% of variance explained. In the concurrent criterion-related validity, several significant correlations were seen close to 0.6, exceeding that value in the correlation between general health and total value of the OMPQ.

Conclusions

The Spanish version of the screening questionnaire OMPQ can be used to identify Spanish patients with musculoskeletal pain at risk of developing a chronic disability.

【 授权许可】

   
2014 Cuesta-Vargas and González-Sánchez; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Smith BH, Elliot AM, Chambers WA, Cairns Smith W, Hannaford PC, Penny K: The Impact of Chronic Pain in the Community. Fam Pract 2001, 18:292-299.
• [2]Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G: Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006, 15(2):S192-300.
• [3]Gjesdal S, Bratberg E, Maeland JG: Musculoskeletal impairments in the Norwegian working population: the prognostic role of diagnoses and socioeconomic status: a prospective study of sickness absence and transition to disability pension. Spine 2009, 34(14):1519-1525.
• [4]Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, Owens DK: Clinical Efficacy Assessment Subcommittee of the American College of Physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007, 147(7):478-491.
• [5]Vlaeyen JW, Linton SJ: Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000, 85(3):317-332.
• [6]Westman A, Linton SJ, Ohrvik J, Wahlén P, Leppert J: Do psychosocial factors predict disability and health at a 3-year follow-up for patients with non-acute musculoskeletal pain? A validation of the Orebro Musculoskeletal Pain Screening Questionnaire. Eur J Pain 2008, 12(5):641-649.
• [7]Foster NE, Pincus T, Underwood M, Vogel S, Breen A, Harding G: Treatment and the process of care in musculoskeletal conditions. A multidisciplinary perspective and integration. Orthop Clin North Am 2003, 34(2):239-244.
• [8]Linton SJ, Boersma K: Early identification of patients at risk of developing a persistent back problem: the predictive validity of the Orebro Musculoskeletal Pain Questionnaire. Clin J Pain 2003, 19(2):80-86.
• [9]Maher CG, Grotle M: Evaluation of the predictive validity of the Orebro Musculoskeletal Pain Screening Questionnaire. Clin J Pain 2009, 25(8):666-70.
• [10]Margison DA, French DJ: Predicting treatment failure in the subacute injury phase using the Orebro Musculoskeletal Pain Questionnaire: an observational prospective study in a workers¿ compensation system. J Occup Environ Med 2007, 49(1):59-67.
• [11]Grotle M, Vøllestad NK, Brox JI: Screening for yellow flags in first-time acute low back pain: reliability and validity of a Norwegian version of the Acute Low Back Pain Screening Questionnaire. Clin J Pain 2006, 22(5):458-467.
• [12]Hockings RL, McAuley JH, Maher CG: A systematic review of the predictive ability of the Orebro Musculoskeletal Pain Questionnaire. Spine 2008, 33(15):494-500. doi:10.1097/BRS.0b013e31817ba3bb
• [13]Melloh M, Elfering A, Egli Presland C: Identification of prognostic factors for chronicity in patients with low back pain. A review of screening instruments. Int Orthop 2009, 33:301-313. doi:10.1007/s00264-008-0707-8
• [14]Hill JC, Dunn KM, Main CJ, Hay EM: Subgrouping low back pain: a comparison of the STarT Back Tool with the Orebro Musculoskeletal Pain Screening Questionnaire. Eur J Pain 2010, 14(1):83-89. doi:10.1016/j.ejpain.2009.01.003
• [15]Países de habla hispana promueven uso del español en la ONU. 2013.
• [16]Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R: Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 2002, 324:1417.
• [17]Ware J, Sherbourne C: The MOS 36 ¿item short form health survey (SF¿36) I conceptual frame work and item selection. Med Care 1992, 30:447-483.
• [18]Ware JE, Kosinski M, Turner-Bowker DM, Gandek B: How to score version 2 of the SF-12 Health Survey (with a supplement documenting version 1). QualityMetric Incorporated, Lincoln, RI; 2002.
• [19]Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
• [20]Atkinson G, Nevill AM: Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine. Sports Med 1998, 4:217-238.
• [21]Nevill AM, Atkinson G: Assessing agreement between measurements recorded on a ratio scale in sports medicine and sports science. Br J Sports Med 1997, 3:314-318.
• [22]Mancini M, Salarian A, Carlson-Kuhta P, Zampieri C, King L, Chiari L, Horak FB: ISway: a sensitive, valid and reliable measure of postural control. J Neuroengineering Rehabil 2012, 9:59. BioMed Central Full Text
• [23]Peterson RA: A meta-analysis of variance accounted for and factor loadings in exploratory factor analysis. Mark Lett 2000, 11:261-275.
• [24]Gabel CP, Melloh M, Burkett B, Osborne J, Yelland M: The Örebro Musculoskeletal Screening Questionnaire: validation of a modified primary care musculoskeletal screening tool in an acute work injured population. Man Ther 2012, 17(6):554-65.